BioCentury
ARTICLE | Clinical News

Unigene regulatory update

September 14, 1998 7:00 AM UTC

UGNE received U.S. Patent No. 5,789,234 claiming the gene for the company's amidating enzyme and use of the gene for the production of pharmaceutical peptides. UGNE uses the technology in its manufact...